Newton Biocapital launches new NBC III fun...Newton Biocapital has launched a new life sciences fund with initial capital commitments of €50m and a target size of €150m. more ➔
New funds to boost European life sciences European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris. more ➔
Aicuris licences antisense RNA know-how fr...AiCuris will pay up to €100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients. more ➔
BioNTech collaborates with AGC BiologicsAGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription. more ➔
EU Council confirms European Scale-up Init...EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies. more ➔
Protix raises €50m for expansionDutch insect protein specialist Protix has raised €50m for expansion and development from international investors and the ECBF. more ➔
Viennese Ribbon Biolabs closes €18m Seri...Ribbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures more ➔
mRNA specalist Ethris raises $26m in Serie...German mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital. more ➔
Evotec and Boehringer Ingelheim enter drug... Evotec SE will use its PanOmics platform to validate and screen targets and drug candidates in ophtalmology for Boehringer Ingelheim. more ➔
BioNTech and Pfizer evaluate Omicron-speci...Pfizer Inc and BioNTech SE have started clinical safety testing of an Omikron-specific vaccine in healthy adults 18 through 55 years of age. more ➔
